News & Press Releases: Breaking News

FDA continues efforts to stop stem cell clinics and manufacturers from marketing unapproved products

Thursday, April 4, 2019  
Share |

The US Food and Drug Administration (FDA) has released a statement about the agency’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk. The ISCT Global Government and Public Relations Committee supports the FDA’s ongoing commitment to helping advance legitimate stem cell therapy development under existing agency regulations. (https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635165.htm)


© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy